Patents by Inventor Francesca Fallarino

Francesca Fallarino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150044109
    Abstract: An apparatus for production of microcapsules includes a volumetric pump configured to deliver a polysaccaridic suspension through a catching tube. A needle-type element is configured to receive the suspension through the catching tube, and the needle-type element has a button hole opening in a lateral wall thereof and an output hole that outputs the suspension. The button hole opening receives a pressure fluid current. A pressure regulator is coupled to the button hole opening to regulate the pressure fluid current to interrupt a suspension flow and obtain microdroplets of homogeneous size exiting the output hole. The microdroplets are received in a receiving container in a solution including divalent cations or polycationic substances to form a gel such that homogeneous microcapsules are formed.
    Type: Application
    Filed: October 14, 2014
    Publication date: February 12, 2015
    Inventors: Riccardo Calafiore, Giovanni Luca, Mario Calvitti, Ennio Becchetti, Paolo Puccetti, Francesca Fallarino, Claudio Nastruzzi
  • Patent number: 8865218
    Abstract: The invention relates to the use of Sertoli cells (SC) microencapsulated into hydrogel-based microcapsules, for the prevention and/or treatment of Type 1 diabetes mellitus (T1DM) and to a process for producing microcapsules, preferably shaped as microspheres.
    Type: Grant
    Filed: December 18, 2009
    Date of Patent: October 21, 2014
    Assignee: GH Care, Inc.
    Inventors: Riccardo Calafiore, Giovanni Luca, Mario Calvitti, Ennio Becchetti, Paolo Puccetti, Francesca Fallarino, Claudio Nastruzzi
  • Publication number: 20110250280
    Abstract: The invention relates to the use of Sertoli cells (SC) microencapsulated into hydrogel-based microcapsules, for the prevention and/or treatment of Type 1 diabetes mellitus (T1DM) and to a process for producing microcapsules, preferably shaped as microspheres.
    Type: Application
    Filed: December 18, 2009
    Publication date: October 13, 2011
    Inventors: Riccardo Calafiore, Giovanni Luca, Mario Calvitti, Ennio Becchetti, Paolo Puccetti, Francesca Fallarino, Claudio Nastruzzi
  • Patent number: 6716422
    Abstract: The invention provides methods of inducing the production of cytolytic T lymphocytes directed against malignancy or infectious agent by a mammal and treating such disease such that deleterious side effects are minimized and treatment of metastatic melanomas are surprisingly and dramatically improved.
    Type: Grant
    Filed: October 8, 1998
    Date of Patent: April 6, 2004
    Assignees: ARCH Development Corporation, Genetics Institute Incorporated
    Inventors: Thomas F. Gajewski, Francesca Fallarino
  • Patent number: 6080399
    Abstract: The invention provides methods of inducing the production of cytolytic T lymphocytes directed against malignancy or infectious agent by a mammal and treating such disease such that deleterious side effects are minimized and treatment of metastatic melanomas are surprisingly and dramatically improved.
    Type: Grant
    Filed: April 23, 1998
    Date of Patent: June 27, 2000
    Assignee: Arch Development Corporation
    Inventors: Thomas F. Gajewski, Francesca Fallarino